Anti-high mobility group box-1 monoclonal antibody treatment of brain edema induced by influenza infection and lipopolysaccharide

Anti–high mobility group box 1 monoclonal antibody improves ischemia/reperfusion injury and mode of liver regeneration after partial hepatectomy

(2016) Masahiro Sugihara et al.   AMERICAN JOURNAL OF SURGERY

Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease

(2016) Tatsuya Sasaki et al.   EXPERIMENTAL NEUROLOGY

HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease

(2016) Barry W. Festoff et al.   Journal of Neuroinflammation

Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats

(2016) Jun Haruma et al.   Scientific Reports

HMGB1 in health and disease

(2014) Rui Kang et al.   MOLECULAR ASPECTS OF MEDICINE

Unknown

(2014) Melinda Magna et al.   MOLECULAR MEDICINE

High mobility group box 1 in patients with 2009 pandemic H1N1 influenza-associated encephalopathy

(2013) Hiroshi Momonaka et al.   BRAIN & DEVELOPMENT

Transcriptome profiling of brain edemas caused by influenza infection and lipopolysaccharide treatment

(2013) Yukihiro Kyan et al.   JOURNAL OF MEDICAL VIROLOGY

Anti-high mobility group box-1 antibody therapy for traumatic brain injury

(2012) Yu Okuma et al.   ANNALS OF NEUROLOGY

Unexpected cardiopulmonary arrest associated with influenza: our experience during the 2009 pandemic in Japan

(2012) Akihisa Okumura et al.   Influenza and Other Respiratory Viruses

Severe form of encephalopathy associated with 2009 pandemic influenza A (H1N1) in Japan

(2012) Akihisa Okumura et al.   JOURNAL OF CLINICAL VIROLOGY

National survey of pandemic influenza A (H1N1) 2009-associated encephalopathy in Japanese children

(2012) Hisashi Kawashima et al.   JOURNAL OF MEDICAL VIROLOGY

HMGB1 Protein Binds to Influenza Virus Nucleoprotein and Promotes Viral Replication

(2012) D. Moisy et al.   JOURNAL OF VIROLOGY

Treatment of pandemic influenza A (H1N1) 2009-associated encephalopathy in children

(2012) Hisashi Kawashima et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 influenza-infected children

(2011) Yoshinori Ito et al.   CYTOKINE

Anti-high Mobility Group Box-1 Monoclonal Antibody Protects the Blood–Brain Barrier From Ischemia-Induced Disruption in Rats

(2011) Jiyong Zhang et al.   STROKE

Lipopolysaccharide treatment and inoculation of influenza A virus results in influenza virus–associated encephalopathy–like changes in neonatal mice

(2010) Tomohisa Tanaka et al.   JOURNAL OF NEUROVIROLOGY

Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection

(2008) Takashi Ichiyama et al.   BRAIN & DEVELOPMENT

Serum and CSF levels of cytokines in acute encephalopathy following prolonged febrile seizures

(2007) Takashi Ichiyama et al.   BRAIN & DEVELOPMENT